Incannex Healthcare begins Phase 2 rheumatoid arthritis trial

MELBOURNE: Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has kicked off a Phase 2 clinical trial, testing

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In